V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough
MedTech & Diagnostics

Envista Holdings Executive Compensation (FY25)

NVST · Executive and director compensation, fiscal 2022 to 2025
Chief executive, fiscal 2025
◇
Paul Keel
Latest say-on-pay support
=
May 19, 2026
Chief executive pay ratio
◇
To the median employee
Velarion Member: every covered company in MedTech & Diagnostics, with dashboards, peer screens and board-ready briefs. Three seats, one year.
Email me this page as a cited PDF — sent in 2 minutes
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.

The paid brief on Envista Holdings

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $499 for the board report; $2,400 for both.
Get the executive briefGet the board briefNo account needed.
Data as of October 22, 2026Latest filing (8-K): May 21, 2026
11 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Envista Holdings brief$1,500Get the executive brief
Velarion Member, one year
330 figures on this page: 323 cited to the filing that reported them, 7 calculated from figures it prints. See the citations

More on Envista Holdings

Five data products on this company. Each one is requested through the developer setup page.
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Paul Keel: $24,236,357 → $10,559,567 (56.4% lower)
CEO pay ratio: 618:1 → 183:1 (70.4% lower)

Frequently asked questions

Answers drawn from the data on this page.
Who is Envista Holdings' chief executive and what were they paid?
Total compensation for Paul Keel, President & Chief Executive Officer, came to $10,559,567 in fiscal 2025. Keel's total was 56.4% lower than the $24,236,357 reported for fiscal 2024.
What was Envista Holdings' say-on-pay result?
Shareholders supported the say-on-pay proposal with 96.5% of votes cast including abstentions in favor at the meeting held May 19, 2026 for fiscal 2025.
Which companies are in Envista Holdings' peer group?
Companies named in the disclosed peer group include Align Technology, Inc., CONMED Corporation, DENTSPLY SIRONA Inc., Enovis Corporation and Haemonetics Corporation, among others.
What is Envista Holdings' chief executive pay ratio?
For fiscal 2025, the company reported a chief executive pay ratio of 183:1, against median employee compensation of $57,572.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Amir Aghdaei
President & CEO
◇—◇◇◇—◇◇
Howard Yu
Senior Vice President and CFO
◇—◇◇◇—◇◇
Patrik Eriksson
SVP and President of Nobel Biocare
◇—◇◇◇—◇◇
Jean-Claude Kyrillos
SVP and President, Diagnostics and Digital Solutions
◇—◇◇◇—◇◇
Mark Nance
SVP and General Counsel
◇—◇◇◇—◇◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Amir Aghdaei
President & CEO
◇—◇◇——◇◇
Howard Yu
Senior Vice President and CFO, until September 22, 2023
◇—◇◇——◇◇
Eric Conley
President, Orthodontics
◇—◇◇◇—◇◇
Jean-Claude Kyrillos
SVP and President, Diagnostics and Digital Solutions, until June 30, 2023
◇—◇◇——◇◇
Patrik Eriksson
SVP and President of Nobel Biocare, until December 31, 2023
◇—◇◇◇—◇◇
Mark Nance
SVP and General Counsel
◇—◇◇——◇◇
Stephen Keller
Principal Financial Officer
◇—◇◇——◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Paul Keel
President & CEO, from May 1, 2024
◇◇◇◇◇—◇◇
Amir Aghdaei
President & CEO, until May 1, 2024
◇—◇◇◇—◇◇
Eric Hammes
Chief Financial Officer, from August 1, 2024
◇◇◇—◇—◇◇
Mark Nance
SVP and General Counsel
◇—◇◇◇—◇◇
Robert Befidi
President, Diagnostics
◇—◇◇◇—◇◇
Mischa Reis
SVP, Strategy and Business Development
◇—◇◇◇—◇◇
Stephen Keller
Principal Financial Officer, until August 1, 2024
◇—◇◇——◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Paul Keel
President & Chief Executive Officer
◇—◇◇◇—◇◇
Eric Hammes
Senior Vice President and Chief Financial Officer
◇—◇◇◇—◇◇
Mark Nance
Senior Vice President, General Counsel and Secretary
◇—◇◇◇—◇◇
Veronica Acurio
President, Orthodontics
◇—◇◇◇—◇◇
Robert Befidi
President, Diagnostics
◇—◇◇◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Eric HammesOPTION◇——◇—◇◇
Eric HammesRSU◇——◇——◇
Eric HammesPSU◇◇◇—◇—◇
Mark NanceRSU◇——◇——◇
Mark NanceOPTION◇——◇—◇◇
Mark NancePSU◇◇◇—◇—◇
Paul KeelRSU◇——◇——◇
Paul KeelPSU◇◇◇—◇—◇
Paul KeelOPTION◇——◇—◇◇
Robert BefidiPSU◇◇◇—◇—◇
Robert BefidiRSU◇——◇——◇
Robert BefidiOPTION◇——◇—◇◇
Veronica AcurioRSU◇——◇——◇
Veronica AcurioOPTION◇——◇—◇◇
Veronica AcurioPSU◇◇◇—◇—◇
Fiscal 2022, 2023, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Veronica AcurioRSU◇◇——
Option◇—◇2/25/2035
RSU◇◇——
RSU◇◇——
Robert BefidiRSU◇◇——
Option◇—◇2/25/2034
RSU◇◇——
Option◇—◇2/25/2035
RSU◇◇——
RSU◇◇——
RSU◇◇——
Mark NanceRSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇2/25/2034
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇2/25/2035
Option◇—◇2/25/2033
Paul KeelOption◇—◇5/25/2034
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇5/25/2034
RSU◇◇——
RSU◇◇——
Option◇—◇2/25/2035
Eric HammesOption◇—◇2/25/2035
RSU◇◇——
RSU◇◇——
RSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Severance and change in control

The terms as written in the agreements.
Paul Keel
President & Chief Executive Officer · Employment agreement
Non-compete period◇
Non-solicit period◇

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Scott Huennekens
Board chair
◇◇————◇
Christine Tsingos
◇◇————◇
Wendy Carruthers
◇◇————◇
Kieran T. Gallahue
◇◇————◇
Daniel A. Raskas
◇◇————◇
Barbara Hulit
◇◇————◇
Vivek Jain
◇◇————◇
J. Andrew Pierce
◇◇————◇
Paul Keel served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Board chair premium◇
Audit committee chair◇
Compensation committee chair◇
Nominating and governance chair◇
Board meeting fee◇
Committee meeting fee◇

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • Align Technology, Inc. ALGN
  • CONMED Corporation CNMD
  • DENTSPLY SIRONA Inc. XRAY
  • Enovis Corporation ENOV
  • Haemonetics Corporation HAE
  • Henry Schein, Inc. HSIC
  • Hologic, Inc. HOLX
  • ICU Medical, Inc. ICUI
  • Integer Holdings Corporation ITGR
  • Integra LifeSciences Holdings Corp. IART
  • Merit Medical Systems, Inc. MMSI
  • Revvity, Inc. RVTY
  • Teleflex Incorporated TFX
  • The Cooper Companies, Inc. COO

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025May 19, 2026=◇◇◇
2024June 10, 2025=◇◇◇
2023May 21, 2024=◇◇◇
2022May 23, 2023=◇◇◇
2021May 24, 2022=◇◇◇
2020May 25, 2021=◇◇◇
2019May 27, 2020=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇

Velarion Pro: every company page, peer tools and exports, one seat

One seat, one person. It opens the whole platform: the peer tools, the written analysis and the exports, on every company we cover. Join the list and you will hear from us when it opens.
Your address is used for this and nothing else, and you can unsubscribe in one click. See the privacy policy.
Tell me when Envista Holdings files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Envista Holdings disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Envista Holdings sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $499
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for Peer Group Review
Whether Envista Holdings' disclosed peer group is defensible, who names Envista Holdings back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
330 figures on this page: 323 cited to the filing that reported them, 7 calculated from figures it prints.
323 cited to the filing
7 calculated from the filing

Documents cited

  1. 0001757073-26-000043
    ITEM 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
  2. 0001757073-26-000031
    CEO Pay Ratio · Director Compensation · Director Compensation Structure · Grants of Plan-Based Awards for Fiscal 2025 · and 2 more sections
  3. 0001628280-25-031044
    ITEM 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
  4. 0001757073-25-000018
    Summary Compensation Table
  5. 0001757073-24-000056
    Item 5.07 Submission of Matters to a Vote of Security Holders
  6. 0001757073-24-000036
    Exhibit
  7. 0001757073-24-000033
    Summary Compensation Table
  8. 0001757073-23-000051
    Item 5.07 Submission of Matters to a Vote of Security Holders
  9. 0001757073-22-000065
    Item 5.07 Submission of Matters to a Vote of Security Holders
  10. 0001757073-21-000076
    Item 5.07 Submission of Matters to a Vote of Security Holders
  11. 0001757073-20-000027
    Item 5.07 Submission of Matters to a Vote of Security Holders
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Envista Holdings executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/NVST (accessed 2026).
Short form: data: Velarion

The paid brief for Envista Holdings

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $499 for the board report; $2,400 for both.
Get the executive briefGet the board briefNo account needed.
11 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Envista Holdings and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

MedTech & Diagnostics rankings

Chief executive pay — MedTech & DiagnosticsCEO pay ratio — MedTech & DiagnosticsSay-on-pay support — MedTech & Diagnostics

Peers Envista Holdings discloses

The companies named in NVST's own disclosed peer group.

Align Technology, Inc.CONMED CorporationDENTSPLY SIRONA Inc.Enovis CorporationHaemonetics CorporationHenry Schein, Inc.Hologic, Inc.ICU Medical, Inc.Integer Holdings CorporationIntegra LifeSciences Holdings Corp.Merit Medical Systems, Inc.Revvity, Inc.Teleflex IncorporatedThe Cooper Companies, Inc.

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  All companies · The Pay Desk · Methodology · Terms · Privacy